About: Alexandra Boer Kimball

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Alexandra Boer Kimball Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) araştırmacı (tr) wetenschapper (nl) дослідниця (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) հետազոտող (hy)
rdfs:label	Alexandra Boer Kimball (en) Alexandra Boer Kimball (es) Alexandra Boer Kimball (nl) Alexandra Boer Kimball (ast)
skos:prefLabel	Alexandra Boer Kimball (en) Alexandra Boer Kimball (es) Alexandra Boer Kimball (nl) Alexandra Boer Kimball (ast)
name	Alexandra Boer Kimball (en) Alexandra Boer Kimball (es) Alexandra Boer Kimball (nl) Alexandra Boer Kimball (ast)
given name	wds:Q64257169-7BA1D31F-7A81-4ACA-899A-7EFB3D2DB9AD
given name	Alexandra
instance of	wds:Q64257169-62A21AC6-D020-494A-9794-C5527E82EB0C
instance of	Homo sapiens
occupation	wds:Q64257169-FCEB1884-4A15-444D-B235-8A578C56CC7E
sex or gender	wds:Q64257169-A268067E-D6C4-4014-B93C-75848581AAD0
ISNI	wds:Q64257169-21FD2C62-0A6B-4DB4-A37F-0AED7662C824
VIAF ID	wds:Q64257169-51BC2390-E992-41D0-9E07-1BEA7E3665BE
IdRef ID	wds:Q64257169-ECC481CB-44EA-4780-B250-62B902728D7D
National Library of Korea ID	wds:Q64257169-D65F01AE-FDF6-45B8-BD8E-37DD3EEF8E9C
WorldCat Identities ID (superseded)	wds:Q64257169-86C7598E-6554-4B47-8C52-09B359EF7170
VIAF ID	http://viaf.org/viaf/260936409
IdRef ID	http://www.idref.fr/17031393X/id
National Library of Korea ID	http://lod.nl.go.kr/resource/KAC200702302
occupation	researcher
sex or gender	female organism
ISNI	0000000419893777
VIAF ID	260936409
IdRef ID	17031393X
National Library of Korea ID	KAC200702302
WorldCat Identities ID (superseded)	lccn-n2004009619
ORCID iD	wds:Q64257169-50E9AE33-F1D3-4427-A220-2D7A2852681D
ORCID iD	https://orcid.org/0000-0001-9405-0479
ORCID iD	0000-0001-9405-0479
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64257169
is author of	Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne Psoriasis and Cardiovascular Disease. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. The psychosocial burden of psoriasis. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis An assessment of the cost-utility of therapy for psoriasis. Quantifying the harmful effect of psoriasis on health-related quality of life A single-blinded, randomized, controlled clinical trial evaluating the effect of face washing on acne vulgaris The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. Psoriasis prevalence among the 2009 AAD National Melanoma/Skin Cancer Screening Program participants. Cutaneous manifestations of thyroid disease Reporting of ethical review of clinical research submitted to the Journal of the American Academy of Dermatology. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. Psoriasis epidemiology: the interplay of genes and the environment. Assessing the role of race in quantitative measures of skin pigmentation and clinical assessments of photosensitivity. Conditioned pharmacotherapeutic effects: a preliminary study. Update on biologic safety for patients with psoriasis during pregnancy Pregnancy outcomes in psoriasis: why do we know so little? Latitude and psoriasis prevalence. The impact of psoriasis on pregnancy outcomes Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial. Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09. Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment. Quality of life considerations in psoriasis treatment. Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy A pilot study of etanercept treatment for pemphigus vulgaris Psoriasis and the life cycle of persistent life effects Fate of manuscripts declined by the Journal of the American Academy of Dermatology. Targeted Reminder Phone Calls to Patients at High Risk of No-Show for Primary Care Appointment: A Randomized Trial. A novel approach to administration of peptides in women: Systemic absorption of a GnRH agonist via transvaginal ring delivery system Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. US dermatology residents' satisfaction with training and mentoring: survey results from the 2005 and 2006 Las Vegas Dermatology Seminars. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study Dermatology urgent care: enlisting help from primary care in triage decisions Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Face time versus test ordering: is there a trade-off? Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Brodalumab and suicidal ideation in the context of a recent economic crisis in the United States. Psoriasis: is the impairment to a patient's life cumulative?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software